GHRP-2 (5mg x 10), CJC-1295 no DAC (5mg x 10)

GHRP-2 and CJC-1295 no DAC (Mod GRF 1-29) are synthetic research peptides used together in experimental models to investigate growth hormone axis regulation and somatotropic signaling pathways. GHRP-2 is a potent hexapeptide growth hormone secretagogue that activates the growth hormone secretagogue receptor (GHS-R1a), triggering Gq/PLC-dependent calcium signaling involved in GH release and hypothalamic–pituitary feedback regulation. CJC-1295 no DAC is a stabilized analog of growth hormone–releasing hormone (GHRH 1-29) that selectively activates the GHRH receptor, stimulating adenylate cyclase and cAMP-mediated signaling in pituitary somatotrophs. Preclinical research employs the combined activation of GHS-R1a and GHRH receptors to examine synergistic GH secretion, receptor pharmacology, and endocrine signaling dynamics in controlled laboratory settings.

Disclaimer: All products sold on this website are intended for research and identification purposes only. These products are not intended for human dosing, injection, or ingestion. The products and statements on this website have not been evaluated by the U.S. Food and Drug Administration (FDA). These compounds are intended for laboratory research use only. They are not for human consumption, medical, veterinary, or household use. Nothing on this website should be construed as medical advice or as a substitute for professional medical consultation. By purchasing, you agree that you are a qualified researcher and understand the proper handling and storage of these materials.